22232 Federal Register / Vol. 80, No. 76 / Tuesday, April 21, 2015 / Notices 

1Notice of United States Postal Service of Filing 

a Functionally Equivalent Global Reseller 

Expedited Package 1 Negotiated Service Agreement 

and Application for Non-Public Treatment of 

Materials Filed Under Seal, April 13, 2015 (Notice). 

ADAMS Public Documents collection at 

http://www.nrc.gov/reading-rm/

adams.html. To begin the search, select 

‘‘ADAMS Public Documents’’ and then 

select ‘‘Begin Web-based ADAMS 

Search.’’ For problems with ADAMS, 

please contact the NRC’s Public 

Document Room (PDR) reference staff at 

1–800–397–4209, 301–415–4737, or by 

email to pdr.resource@nrc.gov. The 

ADAMS accession number for each 

document referenced (if it available in 

ADAMS) is provided the first time that 

a document is referenced. The draft 

environmental impact statement (EIS) is 

available in ADAMS under accession 

Nos. ML15103A012 and ML15103A025, 

respectively. 

• NRC’s PDR: You may examine and 

purchase copies of public documents at 

the NRC’s PDR, Room O1–F21, One 

White Flint North, 11555 Rockville 

Pike, Rockville, Maryland 20852. 

• Project Web site: The draft EIS can 

be accessed online at the Bell Bend COL 

specific Web page at: http://

www.nrc.gov/reactors/new-reactors/col/

bell-bend.html. 

B. Submitting Comments 

Please include Docket ID NRC–2008– 

0603 in the subject line of your 

comment submission. 

The NRC cautions you not to include 

identifying or contact information that 

you do not want to be publicly 

disclosed in your comment submission. 

The NRC posts all comment 

submissions at http://

www.regulations.gov as well as entering 

the comment submissions into ADAMS. 

The NRC does not routinely edit 

comment submissions to remove 

identifying or contact information. 

If you are requesting or aggregating 

comments from other persons for 

submission to the NRC, then you should 

inform those persons not to include 

identifying or contact information that 

they do not want to be publicly 

disclosed in their comment submission. 

Your request should state that the NRC 

does not routinely edit comment 

submissions to remove such information 

before making the comment 

submissions available to the public or 

entering the comment submissions into 

ADAMS. 

II. Background 

The NRC is issuing for public 

comment NUREG–2179, ‘‘Draft 

Environmental Impact Statement for the 

Combined License (COL) for the Bell 

Bend Nuclear Power Plant.’’ The PPL 

submitted an application for the COL to 

construct and operate one new nuclear 

power plant at its BBNPP site, located 

in Luzerne County, Pennsylvania. The 

application was submitted by letter 

dated October 10, 2008, pursuant to part 

52 of Title 10 of the Code of Federal 

Regulations (CFR). A notice of receipt 

and availability of the application 

including the environmental report was 

published in the Federal Register on 

November 13, 2008 (73 FR 67214). A 

notice of acceptance for docketing of the 

COL application was published in the 

Federal Register on December 29, 2008 

(73 FR 79519). A notice of intent to 

prepare a draft EIS and to conduct 

scoping was published in the Federal 

Register on January 6, 2009 (74 FR 470). 

On March 30, 2012, PPL submitted a 

revised environmental report (Part 3 of 

the COL application), in accordance 

with 10 CFR 51.45 and 51.50, to provide 

detailed information regarding the 

revised site layout that was developed 

in order to avoid wetland impacts by 

relocating the power block footprint and 

other plant components. A notice of 

intent to conduct a supplemental 

scoping process on the revised site 

layout was published in the Federal 

Register on June 15, 2012 (77 FR 36012). 

The draft EIS also supports the 

USACE’s review and was prepared in 

accordance with the National 

Environmental Policy Act of 1969, as 

amended. The draft EIS also supports 

the USACE’s review of the Department 

of the Army permit application from 

PPL (CENAB–OP–RPA–2008–01401). 

The USACE’s Public Interest Review 

will be part of its Record of Decision 

and is not addressed in the draft EIS. As 

part of the USACE public comment 

process, the USACE will publish a 

notice (in the Federal Register) within 

30 days of the publication of the draft 

EIS to solicit comments from the public 

regarding PPL’s Department of the Army 

permit application for proposed work at 

the BBNPP site. 

II. Request for Comment and Public 

Meetings 

The NRC is requesting public 

comments on the draft EIS. The NRC 

and USACE staff will conduct two 

public meetings to present an overview 

of the draft EIS and to accept public 

comments on both the document and 

the associated Department of the Army 

permit application on Thursday, June 4, 

2015, at Bloomsburg University, 

Monty’s Building Upper Campus, 400 

East Second Street, Bloomsburg, 

Pennsylvania 17815. The first meeting 

will convene at 3:00 p.m. and will 

continue until 5:30 p.m., as necessary. 

The second meeting will convene at 

7:30 p.m., with a repeat of the overview 

portions of the first meeting, and will 

continue until 10:00 p.m., as necessary. 

For additional information regarding the 

meetings, see the NRC’s Public Meeting 

Schedule Web site at https://

meetings.nrc.gov/pmns/mtg. The agenda 

will be posted no later than 10 days 

prior to the meetings. 

Dated at Rockville, Maryland, this 14th day 

of April 2015. 

For the Nuclear Regulatory Commission. 

Mark Delligatti, 

Deputy Director, Division of New Reactor 

Licensing, Office of New Reactors. 

[FR Doc. 2015–09274 Filed 4–20–15; 8:45 am] 

BILLING CODE 7590–01–P 

POSTAL REGULATORY COMMISSION 

[Docket No. CP2015–59; Order No. 2442] 

New Postal Product 

AGENCY: Postal Regulatory Commission. 

ACTION: Notice. 

SUMMARY: The Commission is noticing a 

recent Postal Service filing concerning 

an addition of Global Reseller Expedited 

Package Contracts 1 to the competitive 

product list. This notice informs the 

public of the filing, invites public 

comment, and takes other 

administrative steps. 

DATES: Comments are due: April 22, 

2015. 

ADDRESSES: Submit comments 

electronically via the Commission’s 

Filing Online system at http://

www.prc.gov. Those who cannot submit 

comments electronically should contact 

the person identified in the FOR FURTHER

INFORMATION CONTACT section by 

telephone for advice on filing 

alternatives. 

FOR FURTHER INFORMATION CONTACT: 

David A. Trissell, General Counsel, at 

202–789–6820. 

SUPPLEMENTARY INFORMATION: 

Table of Contents 

I. Introduction 

II. Notice of Commission Action 

III. Ordering Paragraphs 

I. Introduction 

On April 13, 2015, the Postal Service 

filed notice that it has entered into an 

additional Global Reseller Expedited 

Package Contracts 1 (GREP 1) negotiated 

service agreement (Agreement).1

To support its Notice, the Postal 

Service filed a copy of the Agreement, 

a copy of the Governors’ Decision 

authorizing the product, a certification 


tkelley on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 80, No. 76 / Tuesday, April 21, 2015 / Notices 22233 

of compliance with 39 U.S.C. 3633(a), 

and an application for non-public 

treatment of certain materials. It also 

filed supporting financial workpapers. 

II. Notice of Commission Action 

The Commission establishes Docket 

No. CP2015–59 for consideration of 

matters raised by the Notice. 

The Commission invites comments on 

whether the Postal Service’s filing is 

consistent with 39 U.S.C. 3632, 3633, or 

3642, 39 CFR part 3015, and 39 CFR 

part 3020, subpart B. Comments are due 

no later than April 22, 2015. The public 

portions of the filing can be accessed via 

the Commission’s Web site (http://

www.prc.gov). 

The Commission appoints Curtis E. 

Kidd to serve as Public Representative 

in this docket. 

III. Ordering Paragraphs 

It is ordered: 

1. The Commission establishes Docket 

No. CP2015–59 for consideration of the 

matters raised by the Postal Service’s 

Notice. 

2. Pursuant to 39 U.S.C. 505, Curtis E. 

Kidd is appointed to serve as an officer 

of the Commission to represent the 

interests of the general public in this 

proceeding (Public Representative). 

3. Comments are due no later than 

April 22, 2015. 

4. The Secretary shall arrange for 

publication of this order in the Federal 

Register. 

By the Commission. 

Shoshana M. Grove, 

Secretary. 

[FR Doc. 2015–09031 Filed 4–20–15; 8:45 am] 

BILLING CODE 7710–FW–P 

REAGAN-UDALL FOUNDATION FOR 

THE FOOD AND DRUG 

ADMINISTRATION 

[BAC 416404] 

Annual Public Meeting; Reagan-Udall 

Foundation for the Food and Drug 

Administration 

ACTION: Notice of annual meeting. 

SUMMARY: The Reagan-Udall Foundation 

for the Food and Drug Administration 

(FDA), which was created by Title VI of 

the Food and Drug Administration 

Amendments Act of 2007, is 

announcing its annual public meeting. 

The purpose of this meeting is to 

provide an opportunity for the 

Foundation to engage with its 

stakeholders and receive public input 

on its efforts. The meeting will include 

an organizational update, project 

updates, panel discussion, and open 

Q & A. 

DATES: The public meeting will be held 

on May 15, 2015, from 10 a.m. until 12 

noon. Registration to attend the meeting 

and requests for oral presentation must 

be received by May 8, 2015. See the 

SUPPLEMENTARY INFORMATION section for 

information on how to register for the 

meeting. 

ADDRESSES: The public meeting will be 

held The Pew Charitable Trusts 

Conference Center, 901 E St. NW., 

Washington, DC 20004. Entrance for the 

meeting is located on 9th St. NW., 

between F St. NW. and E St. NW. 

FOR FURTHER INFORMATION CONTACT: Jane 

Reese-Coulbourne, Reagan-Udall 

Foundation for the FDA, 202–828–1205, 

Meetings@ReaganUdall.org. 

SUPPLEMENTARY INFORMATION: 

I. Background 

The Reagan-Udall Foundation for the 

FDA (the Foundation) is an independent 

501(c)(3) not-for-profit organization 

created by Congress to advance the 

mission of FDA to modernize medical, 

veterinary, food, food ingredient, and 

cosmetic product development; 

accelerate innovation; and enhance 

product safety. With the ultimate goal of 

improving public health, the 

Foundation provides a unique 

opportunity for different sectors (FDA, 

patient groups, academia, other 

government entities, and industry) to 

work together in a transparent way to 

create exciting new research projects to 

advance regulatory science. 

The Foundation acts as a neutral third 

party to establish novel, scientific 

collaborations. Much like any other 

independently developed information, 

FDA evaluates the scientific information 

from these collaborations to determine 

how Reagan-Udall Foundation projects 

can help the Agency to fulfill its 

mission. 

The Foundation’s programmatic 

efforts are designed to improve the 

existing scientific tools (methods) used 

to evaluate products as well as foster the 

development of innovative tools and 

approaches. This is exemplified in the 

Foundation’s projects including: The 

Innovation in Medical Evidence 

Development and Surveillance Program, 

which develops and evaluates methods 

for using observational electronic health 

care data for postmarket evidence 

generation, including postmarket safety 

surveillance; the PredicTox Project, 

which applies systems biology to 

develop mechanistic models to predict 

adverse events; and the Critical Path to 

Tuberculosis Drug Regimens Project, 

which looks at novel approaches to 

development and review of tuberculosis 

combination therapies. Additionally, 

the Foundation is establishing 

regulatory science fellowships as part of 

its broader education efforts aimed at 

building capacity in regulatory science. 

II. Meeting Attendance and 

Participation 

A. Registration 

If you wish to attend the meeting, 

visit: http://goo.gl/GX6ysw. Please 

register for the meeting by May 8, 2015. 

Seating may be limited, so early 

registration is recommended. 

Registration is free and will be on a firstcome, first-served basis. Onsite 

registration on the day of the meeting 

will be based on space availability. 

B. Requests for Oral Comments 

Interested persons may present 

comments at the public meeting. 

Comments will be scheduled to begin 

approximate at 11:40 a.m. Time allotted 

for comments may be limited to 3 

minutes, dependent on number of 

requests received. Those desiring to 

make oral comments should notify Jane 

Reese-Coulbourne (see FOR FURTHER

INFORMATION CONTACT) by May 8, 2015. 

Please include a brief statement of the 

general nature of the comments they 

wish to present along with your name, 

address, telephone number, and email. 

The agenda for the public meeting 

will be posted on the event registration 

page: http://goo.gl/GX6ysw and the 

Reagan-Udall Web site: http://goo.gl/

aSVymH. 

C. Written Comments 

Interested persons may submit either 

electronic or written comments to the 

Foundation at any time to Comments@

ReaganUdall.org, or by mail to the 

Reagan-Udall Foundation for the FDA, 

1025 Connecticut Ave. NW., Suite 1000, 

Washington, DC 20036. Please include 

your name, address, telephone number, 

and email when making comments. 

III. Post-Meeting Materials 

The Foundation plans to make 

meeting materials and meeting 

recording available to the public after 

the meeting. Once available, these 

materials will be posted at http://goo.gl/ 

aSVymH. 

Dated: April 15, 2015. 

Jane Reese-Coulbourne, 

Executive Director, Reagan-Udall Foundation 

for the FDA. 

[FR Doc. 2015–09072 Filed 4–20–15; 8:45 am] 

BILLING CODE 4164–04–P 


tkelley on DSK3SPTVN1PROD with NOTICES